Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Gene Ther. 2010 May 21;17(8):579–584. doi: 10.1038/cgt.2010.14

Fig.4.

Fig.4

LC3-II autophagic forms are produced by Ad-IFNα in cancer cells but not in normal cells which can be inhibited by the autophagy inhibitor, 3-MA. Increases in the LC3-II autophagic forms were seen over time in Ad-IFNα- treated UC-9 cancer cells which could be blocked by exposure of various doses of 3-MA. In contrast no LC3-II was seen in Ad-IFNα treated normal human urothelial cells.